{
  "catalogId": "e60de24d-8db9-4774-811b-e5907e7e5f92",
  "name": "DARZALEX 120 MG/ML S.C. 1,800 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "167 14 36565 00",
  "treatmentDescriptions": "DARZALEX is indicated:Multiple Myeloma• in combination with lenalidomide and dexamethasone or with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.• in combination with bortezomib, thalidomide and dexamethasone for the treatment of adult patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplant.• in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.• as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, whose prior therapy included a proteasome inhibitor and an immunomodulatory agent and who have demonstrated disease progression on the last therapy.•for the treatment of adult patients with multiple myeloma in combination with pomalidomide and dexamethasone in patients who have received at least one prior line of therapy including lenalidomide and a proteasome inhibitor.Light chain (AL) amyloidosis• in combination with cyclophosphamide, bortezomib and dexamethasone for the treatment of adult patients with newly diagnosed systemic AL amyloidosis.",
  "termsOfIssue": "Prescription required",
  "form": "solution for injection",
  "route": "s.c",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "DARATUMUMAB/",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01XC24",
      "name": "DARATUMUMAB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "DARZALEX 120MG/ML S.C 1 800MG (15ML)",
      "manufacturer": {
        "name": "יאנסן סילג",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 15.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "8897",
        "yarpa": "28461",
        "pharmasoft": "4704",
        "barcode": "7290014577657"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 18879.00964,
        "retailMargin": 10.0,
        "maxRetailPrice": 20766.9106,
        "maxPriceWithVAT": 24504.95342
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:44.303133"
  }
}